Daniel J. Becker - Net Worth and Insider Trading
Daniel J. Becker Net Worth
The estimated net worth of Daniel J. Becker is at least $237 Million dollars as of 2024-11-05. Daniel J. Becker is the Director of Pandion Therapeutics Inc and owns about 2,827,883 shares of Pandion Therapeutics Inc (PAND) stock worth over $170 Million. Daniel J. Becker is the Director of Principia Biopharma Inc and owns about 667,600 shares of Principia Biopharma Inc (PRNB) stock worth over $67 Million. Daniel J. Becker is also the Director of Day One Biopharmaceuticals Inc and owns about 5,000 shares of Day One Biopharmaceuticals Inc (DAWN) stock worth over $73,375. Besides these, Daniel J. Becker also holds Acelyrin Inc (SLRN) . Details can be seen in Daniel J. Becker's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Daniel J. Becker has not made any transactions after 2024-07-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Daniel J. Becker
Daniel J. Becker Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel J. Becker owns 4 companies in total, including Principia Biopharma Inc (PRNB) , Pandion Therapeutics Inc (PAND) , and Day One Biopharmaceuticals Inc (DAWN) among others .
Click here to see the complete history of Daniel J. Becker’s form 4 insider trades.
Insider Ownership Summary of Daniel J. Becker
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PRNB | Principia Biopharma Inc | 2020-09-28 | director |
| PAND | Pandion Therapeutics Inc | 2020-11-19 | director & 10 percent owner |
| DAWN | Day One Biopharmaceuticals Inc | 2021-06-01 | director |
 | | 2024-07-17 | director |
Daniel J. Becker Latest Holdings Summary
Daniel J. Becker currently owns a total of 4 stocks. Among these stocks, Daniel J. Becker owns 2,827,883 shares of Pandion Therapeutics Inc (PAND) as of November 19, 2020, with a value of $170 Million and a weighting of 71.74%. Daniel J. Becker owns 667,600 shares of Principia Biopharma Inc (PRNB) as of November 20, 2019, with a value of $67 Million and a weighting of 28.22%. Daniel J. Becker also owns 5,000 shares of Day One Biopharmaceuticals Inc (DAWN) as of June 1, 2021, with a value of $73,375 and a weighting of 0.03%. The other 1 stocks Acelyrin Inc (SLRN) have a combined weighting of 0.01% among all his current holdings.
Latest Holdings of Daniel J. Becker
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PAND | Pandion Therapeutics Inc | 2020-11-19 | 2,827,883 | 60.05 | 169,814,374 |
| PRNB | Principia Biopharma Inc | 2019-11-20 | 667,600 | 100.05 | 66,793,380 |
| DAWN | Day One Biopharmaceuticals Inc | 2021-06-01 | 5,000 | 14.68 | 73,375 |
| SLRN | Acelyrin Inc | 2024-07-17 | 2,999 | 5.92 | 17,754 |
Holding Weightings of Daniel J. Becker
Daniel J. Becker Form 4 Trading Tracker
According to the SEC Form 4 filings, Daniel J. Becker has made a total of 3 transactions in Pandion Therapeutics Inc (PAND) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Pandion Therapeutics Inc is the acquisition of 197,716 shares on November 19, 2020, which cost Daniel J. Becker around $3 Million.
According to the SEC Form 4 filings, Daniel J. Becker has made a total of 1 transactions in Principia Biopharma Inc (PRNB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Principia Biopharma Inc is the acquisition of 55,000 shares on November 20, 2019, which cost Daniel J. Becker around $2 Million.
According to the SEC Form 4 filings, Daniel J. Becker has made a total of 1 transactions in Day One Biopharmaceuticals Inc (DAWN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Day One Biopharmaceuticals Inc is the acquisition of 5,000 shares on June 1, 2021, which cost Daniel J. Becker around $80,000.
More details on Daniel J. Becker's insider transactions can be found in the Insider Trading History of Daniel J. Becker table.Insider Trading History of Daniel J. Becker
- 1
Daniel J. Becker Trading Performance
GuruFocus tracks the stock performance after each of Daniel J. Becker's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Daniel J. Becker is 41.19%. GuruFocus also compares Daniel J. Becker's trading performance to market benchmark return within the same time period. The performance of stocks bought by Daniel J. Becker within 3 months outperforms 7 times out of 9 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Daniel J. Becker's insider trading performs compared to the benchmark.
Performance of Daniel J. Becker
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 6.71 | | | | | |
| Relative Return to S&P 500(%) | 3.83 | | | | | |
Daniel J. Becker Ownership Network
Ownership Network List of Daniel J. Becker
Ownership Network Relation of Daniel J. Becker
Daniel J. Becker Owned Company Details
What does Principia Biopharma Inc do?
Who are the key executives at Principia Biopharma Inc?
Daniel J. Becker is the director of Principia Biopharma Inc. Other key executives at Principia Biopharma Inc include Chief Medical Officer Dolca Thomas , Chief Development Officer Stefani Wolff , and Chief Scientific Officer David M Goldstein .
Principia Biopharma Inc (PRNB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Principia Biopharma Inc (PRNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Principia Biopharma Inc (PRNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Principia Biopharma Inc (PRNB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Principia Biopharma Inc Insider Transactions
Daniel J. Becker Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel J. Becker. You might contact Daniel J. Becker via mailing address: C/o New Leaf Venture Partners, Times Sq Tower, 7 Times Sq, Ste 3502, New York Ny 10036.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
